Indications and results of chemotherapy in children with posttransplant lymphoproliferative disease after liver transplantation

Transplantation

Volumn 69, Issue 5, 2000, Pages 982-984

  Smets, Françoise ^a   Vajro, Pietro ^b   Cornu, Guy ^c   Reding, Raymond ^a   Otte, Jean Bernard ^a   Sokal, Em ^c  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Department of Pediatrics 1301 ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GANCICLOVIR; IMMUNOMODULATING AGENT; INTERFERON; INTERLEUKIN 6 ANTIBODY; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHILD; DISEASE CLASSIFICATION; DRUG INDICATION; DRUG SAFETY; EPSTEIN BARR VIRUS; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034654148     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200003150-00053     Document Type: Article

References (11)

1. Newell KA, Alonso EM, Whitington PF et al. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Transplantation 1996; 62: 370.
2. Sokal EM, Antunes H, Beguin C et al. Early signs and risk factors for the increased incidence of Epstein Barr virus related post transplant lymphoproliferative diseases in paediatric liver transplant recipients treated with Tacrolimus. Transplantation 1997; 64: 1438.
3. Beatty PR, Krams SM, Esquivel CO, Martinez OM. Effect of cyclosporine and tacrolimus on the growth of Epstein-Barr virus transformed B-cell lines. Transplantation 1998; 65: 1248.
4. Swerdlow SH. Post-transplant lymphoproliferative disorders: a working classification. Curr Diagn Pathol 1997; 4: 28.
5. Nalesnik M, Randhawa PS, Demetris AJ, Casavilla A, Fung JJ, Locker J. Lymphoma resembling Hodgkin disease after post-transplant lymphoproliferative disorder in a liver transplant recipient. Cancer 1993; 72: 2568.
6. Sokal EM, Caragiozoglou T, Lamy M, Reding R, Otte JB. Epstein-Barr virus serology and Epstein-Barr virus-associated lymphoproliferative disorders in pediatric liver transplant recipients. Transplantation 1993; 56: 1394.
7. Fischer A, Blanche S, Le Bidois J et al. Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 1991; 324: 1451.
8. Trindade E, Maton P, Reding R, et al. Use of granulocyte macrophage colony stimulating factor in children after orthotopic liver transplantation. J Hepatol 1998; 28: 1054.
9. Gallego-Melcon S, Sanchez de Toledo J, Martinez V, et al. Non-Hodgkin's lymphoma after liver transplantation: response to chemotherapy. Med Pediatr Oncol 1996; 27: 156.
10. Swinnen LJ, Mullen GM, Carr TJ, Costanzo MR, Fisher RI. Aggressive treatment for postcardiac transplant lymphoproliferation. Blood 1995; 86: 3333.
11. Fisher RI, Gaynor ER, Dahlberg S, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993; 328: 1002.